UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Molecular evidence of widespread benzimidazole drug resistance in Ancylostoma caninum from domestic dogs throughout the USA and discovery of a novel β-tubulin benzimidazole resistance mutation

PLoS pathogens, 2023-03, Vol.19 (3), p.e1011146-e1011146

2023

Volltextzugriff (PDF)

Qualitative and quantitative determination of xylazine in oral fluid

Journal of analytical toxicology, 2024-06, Vol.48 (7), p.482

2024

Volltextzugriff (PDF)

Molecular evidence of widespread benzimidazole drug resistance in Ancylostoma caninum from domestic dogs throughout the USA and discovery of a novel [beta]-tubulin benzimidazole resistance mutation

PLoS pathogens, 2023-03, Vol.19 (3), p.e1011146

2023

Volltextzugriff (PDF)

Population-scale long-read sequencing uncovers transposable elements associated with gene expression variation and adaptive signatures in Drosophila

Nature communications, 2022-04, Vol.13 (1), p.1948-1948, Article 1948

2022

Volltextzugriff (PDF)

Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients

The journal of pain, 2020-01, Vol.21 (1-2), p.44-58

2020

Volltextzugriff (PDF)

Monitoring clinical progression with mitochondrial disease biomarkers

Brain (London, England : 1878), 2017-10, Vol.140 (10), p.2530-2540

2017

Volltextzugriff (PDF)

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Cell, 2020-05, Vol.181 (5), p.1016-1035.e19

2020

Volltextzugriff (PDF)

Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity

Journal of the National Comprehensive Cancer Network, 2024-03, Vol.22 (2), p.108

2024

Volltextzugriff (PDF)

The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors

Journal of cancer survivorship, 2022-04, Vol.16 (2), p.223-232

2022

Volltextzugriff (PDF)

Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy

Supportive care in cancer, 2019-10, Vol.27 (10), p.3849-3857

2019

Volltextzugriff (PDF)

Metabolic effects of bezafibrate in mitochondrial disease

EMBO molecular medicine, 2020-03, Vol.12 (3), p.e11589-n/a

2020

Volltextzugriff (PDF)

DNAI2 Mutations Cause Primary Ciliary Dyskinesia with Defects in the Outer Dynein Arm

American journal of human genetics, 2008-11, Vol.83 (5), p.547-558

2008

Volltextzugriff (PDF)

Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes

Journal of the National Comprehensive Cancer Network, 2023-02, Vol.21 (2), p.125

2023

Volltextzugriff (PDF)

Diagnosis of 'possible' mitochondrial disease: an existential crisis

Journal of medical genetics, 2019-03, Vol.56 (3), p.123

2019

Volltextzugriff (PDF)

Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients

Clinical autonomic research, 2022-12, Vol.32 (6), p.497-506

2022

Volltextzugriff (PDF)

Distinct growth regimes of α-synuclein amyloid elongation

Biophysical journal, 2023-06, Vol.122 (12), p.2556-2563

2023

Volltextzugriff (PDF)

De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome

American journal of human genetics, 2017-01, Vol.100 (1), p.138-150

2017

Volltextzugriff (PDF)

Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure

Journal of neurology, neurosurgery and psychiatry, 2014-03, Vol.85 (3), p.331-338

2014

Volltextzugriff (PDF)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Journal of clinical oncology, 2022-05, Vol.40 (14), p.1529-1541

2022

Volltextzugriff (PDF)

Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3031-3031

2023

Volltextzugriff (PDF)

Genetic heterogeneity of motor neuropathies

Neurology, 2017-03, Vol.88 (13), p.1226

2017

Volltextzugriff (PDF)

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

Breast cancer research and treatment, 2019-05, Vol.175 (1), p.217-228

2019

Volltextzugriff (PDF)

The swinging pendulum of biomarkers in mitochondrial disease: The role of FGF21

Neurology, 2016-11, Vol.87 (22), p.2286

2016

Volltextzugriff (PDF)

Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics

Molecular & cellular proteomics, 2016-03, Vol.15 (3), p.892-905

2016

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(58)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(39)
Humans
(29)
Female
(16)
Male
(16)
Adult
(10)
Middle Aged
(10)
Mutation
(10)
Aged
(8)
Clinical Neurology
(8)
Neurosciences & Neurology
(8)
Oncology
(8)
Adolescent
(6)
Animals
(6)
Antineoplastic Agents - Adverse Effects
(6)
Genetics & Heredity
(6)
Peripheral Nervous System Diseases - Chemically Induced
(6)
Child
(5)
Genomes
(5)
Phenotype
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Molecular evidence of widespread benzimidazole drug resistance in Ancylostoma caninum from domestic dogs throughout the USA and discovery of a novel β-tubulin benzimidazole resistance mutation

Qualitative and quantitative determination of xylazine in oral fluid

Molecular evidence of widespread benzimidazole drug resistance in Ancylostoma caninum from domestic dogs throughout the USA and discovery of a novel [beta]-tubulin benzimidazole resistance mutation

Population-scale long-read sequencing uncovers transposable elements associated with gene expression variation and adaptive signatures in Drosophila

Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients

Monitoring clinical progression with mitochondrial disease biomarkers

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity

The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors

Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy

Metabolic effects of bezafibrate in mitochondrial disease

DNAI2 Mutations Cause Primary Ciliary Dyskinesia with Defects in the Outer Dynein Arm

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study

Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes

Diagnosis of 'possible' mitochondrial disease: an existential crisis

Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients

Distinct growth regimes of α-synuclein amyloid elongation

De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome

Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy

Genetic heterogeneity of motor neuropathies

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

The swinging pendulum of biomarkers in mitochondrial disease: The role of FGF21

Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics

Suchergebnisse filtern